# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA659336 | F | Anti viral activity against vaccinia virus in CV-1 (monkey kidney) cells at 1 uM. | Vaccinia virus | 6 | organism-based format | Scientific Literature | ||
2. | ALA659337 | F | Anti viral activity against vaccinia virus in CV-1 (monkey kidney) cells. | Vaccinia virus | 6 | organism-based format | Scientific Literature | ||
3. | ALA672035 | F | The minimum inhibitory concentration was measured on E6SM cells against Vaccinia virus | Vaccinia virus | 16 | organism-based format | Scientific Literature | ||
4. | ALA674923 | F | Inhibitory activity against vaccinia virus (VV) | Vaccinia virus | 39 | organism-based format | Scientific Literature | ||
5. | ALA674924 | F | Inhibitory activity against vaccinia virus (VV). | Vaccinia virus | 11 | organism-based format | Scientific Literature | ||
6. | ALA677523 | F | Concentration required to inhibit Vaccinia induced cytopathicity in E6SM cells by 50% | Vaccinia virus | 9 | organism-based format | Scientific Literature | ||
7. | ALA677528 | F | Antiviral activity against vaccinia virus (VV) in E6SM cell culture | Vaccinia virus | 19 | organism-based format | Scientific Literature | ||
8. | ALA679241 | F | Concentration required to reduce vaccinia virus-inducted cytopathicity by 50% (E6SM cells) | Vaccinia virus | 8 | organism-based format | Scientific Literature | ||
9. | ALA676345 | F | Minimum inhibitory concentration required for antiviral activity to reduce Vaccinia virus (VV) induced cytopathicity in human embryonic skin-muscle cells (ESM) | Vaccinia virus | 16 | organism-based format | Scientific Literature | ||
10. | ALA686413 | F | Antiviral activity against vaccinia virus infected HEF cell lines. | Vaccinia virus | 20 | organism-based format | Scientific Literature | ||
11. | ALA756840 | F | Inhibition of Vaccinia virus induced cytopathicity in in PRK cells. | Vaccinia virus | 16 | organism-based format | Scientific Literature | ||
12. | ALA765387 | F | Minimum inhibitory concentration required to reduce vaccinia virus induced cytopathogenicity by 50% in primary rabbit kidney cells (PRK) | Vaccinia virus | 30 | organism-based format | Scientific Literature | ||
13. | ALA816371 | F | In vitro minimum inhibitory concentration to inhibit VV-induced cytopathogenicity in PRK cells by 50% | Vaccinia virus | 6 | organism-based format | Scientific Literature | ||
14. | ALA816372 | F | Inhibitory concentration against VV in human embryonic skin muscle (ESM) fibroblast cell culture | Vaccinia virus | 10 | organism-based format | Scientific Literature | ||
15. | ALA816373 | F | Minimal inhibitory concentration to reduce virus-induced cytopathicity against VV | Vaccinia virus | 29 | organism-based format | Scientific Literature | ||
16. | ALA816374 | F | Minimum inhibitory concentration required to reduce vaccinia virus (VV) virus-induced cytopathicity by 50% | Vaccinia virus | 13 | organism-based format | Scientific Literature | ||
17. | ALA816375 | F | Inhibitory activity against Vaccinia virus(VV) at a concentration 400 ug/mL; not effective | Vaccinia virus | 1 | organism-based format | Scientific Literature | ||
18. | ALA816376 | F | Inhibitory activity against Vaccinia virus(VV)at a concentration 400 ug/mL; not effective | Vaccinia virus | 3 | organism-based format | Scientific Literature | ||
19. | ALA818722 | F | In vitro antiviral activity against vaccinia virus in Vero cells. | Vaccinia virus | 16 | organism-based format | Scientific Literature | ||
20. | ALA821083 | F | Minimum inhibitory concentration required to reduce vaccinia virus-induced cytopathogenicity in primary rabbit kidney cell cultures | Vaccinia virus | 3 | organism-based format | Scientific Literature |